MEDICAMEQ

Medicamen Biotech Share PriceMedicamen Biotech

₹658.00
35.5 (5.7%)
As on 30 March, 2023 | 07:45 BSE: 531146 NSE: MEDICAMEQ

Medicamen Biotech Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Medicamen Biotech

Start SIP

Medicamen Biotech Share Price

  • Over 1 Month 7.91%
  • Over 3 Month -18.57%
  • Over 6 Month -33.09%
  • Over 1 Year 4.68%

Medicamen Biotech Key Statistics

P/E Ratio 60.7
PEG Ratio -4.6
Market Cap Cr 832
Price to Book Ratio 5.7
EPS 11.8
Dividend 0.2
Relative Strength Index 48.6
Money Flow Index 66.84
MACD Signal -21.62
Average True Range 32.94

Medicamen Biotech Investment Rating

  • Master Rating:
  • Medicamen Biotech has an operating revenue of Rs. 124.96 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Medicamen Biotech Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 34343323
Operating Expenses Qtr Cr 28282718
Operating Profit Qtr Cr 6665
Depreciation Qtr Cr 2222
Interest Qtr Cr 1111
Tax Qtr Cr 0110
Net Profit Qtr Cr 4443

Medicamen Biotech Technicals

EMA & SMA

Current Price
₹658.
35.5 (5.7%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • 641.93
  • 50 Day
  • 688.38
  • 100 Day
  • 743.51
  • 200 Day
  • 776.18
  • 20 Day
  • 638.05
  • 50 Day
  • 693.09
  • 100 Day
  • 769.96
  • 200 Day
  • 813.41

Medicamen Biotech Resistance and Support

PIVOT
₹630.72
Resistance
First Resistance 642.79
Second Resistance 663.07
Third Resistance 675.14
RSI 48.6
MFI 66.84
MACD Single Line -21.62
MACD -15.63
Support
First Resistance 610.44
Second Resistance 598.37
Third Resistance 578.09

Medicamen Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 26,051 1,687,844 64.79
Week 24,285 1,805,818 74.36
1 Month 18,585 1,237,790 66.6
6 Month 12,455 767,880 61.65

Medicamen Biotech Result Highlights

Medicamen Biotech Synopsis

NSE-Medical-Generic Drugs

Medicamen Biotec is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 115.45 Cr. and Equity Capital is Rs. 12.22 Cr. for the Year ended 31/03/2022. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
Market Cap 818
Sales 123
Shares in Float 0.72
No of funds 6
Yield 0.15
Book Value 5.33
U/D Vol ratio 1.2
LTDebt / Equity 3
Alpha 0.07
Beta 1.04

Medicamen Biotech

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 43.21%43.21%43.6%
Mutual Funds
Foreign Portfolio Investors 0.17%1.83%0.35%
Individual Investors 31.36%30.94%35.02%
Others 25.26%24.02%21.03%

Medicamen Biotech Management

Name Designation
Mr. Rahul Bishnoi Chairman
Dr. Vimal Kumar Shrawat Non Executive Director
Mr. Sanjay Bansal Non Executive Director
Mr. Suresh Kumar Singh Non Executive Director
Mr. Ashwani Kumar Sharma Non Executive Director
Ms. Sangeeta Bishnoi Independent Director
Dr. Ravi Kumar Bansal Independent Director
Mr. Harish Pande Independent Director
Mr. Arun Kumar Independent Director
Ms. Sumita Dwivedi Independent Director

Medicamen Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicamen Biotech MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

Medicamen Biotech share price is ₹658 As on 30 March, 2023 | 07:31

What is the Market Cap of Medicamen Biotech ?

The Market Cap of Medicamen Biotech is ₹832.4 Cr As on 30 March, 2023 | 07:31

What is the P/E ratio of Medicamen Biotech ?

The P/E ratio of Medicamen Biotech is 60.7 As on 30 March, 2023 | 07:31

What is the PB ratio of Medicamen Biotech ?

The PB ratio of Medicamen Biotech is 5.7 As on 30 March, 2023 | 07:31

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number